机译:目前的治疗趋势与更好的预测工具在乳房原位的管道癌中的管理中
Univ Edinburgh Western Gen Hosp Breast Canc Now Edinburgh Res Team Edinburgh Midlothian;
Univ Edinburgh Western Gen Hosp Breast Canc Now Edinburgh Res Team Edinburgh Midlothian;
Univ Edinburgh Western Gen Hosp Edinburgh Breast Unit Edinburgh Midlothian Scotland;
Univ Edinburgh Western Gen Hosp Breast Canc Now Edinburgh Res Team Edinburgh Midlothian;
Univ Edinburgh Western Gen Hosp Breast Canc Now Edinburgh Res Team Edinburgh Midlothian;
Western Gen Hosp Dept Pathol Edinburgh Midlothian Scotland;
Univ Edinburgh Western Gen Hosp Edinburgh Breast Unit Edinburgh Midlothian Scotland;
DCIS; Ductal carcinoma in situ; Breast cancer; Risk prediction; Prognostic tools; Patient stratification;
机译:目前的治疗趋势与更好的预测工具在乳房原位的管道癌中的管理中
机译:浸润前性乳腺疾病的诊断和管理:原位导管癌(DCIS)和非典型导管增生(ADH)–当前定义和分类
机译:乳腺导管癌的单侧和对侧预防乳房切除术的趋势:模式和预测因子
机译:假设和实践:对乳房原位的导管癌有几种治疗方法?
机译:14-3-3 Zeta介导的上皮-间质转化(EMT)有助于ErbB2过表达导管原位癌(DCIS)演变为浸润性乳腺癌
机译:浸润前乳腺疾病的诊断和管理:原位导管癌(DCIS)和非典型导管增生(ADH)–当前定义和分类
机译:浸润前乳腺疾病的诊断和管理:原位导管癌(DCIS)和非典型导管增生(ADH)–当前定义和分类